Free Trial

Accuray (ARAY) Competitors

Accuray logo
$1.92 -0.09 (-4.48%)
Closing price 03/3/2025 04:00 PM Eastern
Extended Trading
$1.91 -0.01 (-0.52%)
As of 03/3/2025 06:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ARAY vs. OFIX, SRDX, ANGO, RMTI, RSLS, ABT, ISRG, BSX, SYK, and MDT

Should you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT). These companies are all part of the "health care equipment" industry.

Accuray vs.

Accuray (NASDAQ:ARAY) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, community ranking, media sentiment, analyst recommendations, profitability and dividends.

Accuray has higher earnings, but lower revenue than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accuray$453.14M0.44-$15.55M-$0.05-38.40
Orthofix Medical$799.49M0.81-$151.40M-$3.29-5.16

Accuray has a net margin of -0.96% compared to Orthofix Medical's net margin of -15.18%. Accuray's return on equity of -9.75% beat Orthofix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Accuray-0.96% -9.75% -0.93%
Orthofix Medical -15.18%-21.25%-13.29%

Orthofix Medical has a consensus target price of $23.33, suggesting a potential upside of 37.42%. Given Orthofix Medical's stronger consensus rating and higher possible upside, analysts plainly believe Orthofix Medical is more favorable than Accuray.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accuray
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Orthofix Medical
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

64.1% of Accuray shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 4.2% of Accuray shares are owned by company insiders. Comparatively, 2.6% of Orthofix Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Accuray has a beta of 1.51, meaning that its share price is 51% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500.

Orthofix Medical received 85 more outperform votes than Accuray when rated by MarketBeat users. However, 65.55% of users gave Accuray an outperform vote while only 62.20% of users gave Orthofix Medical an outperform vote.

CompanyUnderperformOutperform
AccurayOutperform Votes
333
65.55%
Underperform Votes
175
34.45%
Orthofix MedicalOutperform Votes
418
62.20%
Underperform Votes
254
37.80%

In the previous week, Orthofix Medical had 22 more articles in the media than Accuray. MarketBeat recorded 24 mentions for Orthofix Medical and 2 mentions for Accuray. Accuray's average media sentiment score of 0.47 beat Orthofix Medical's score of 0.05 indicating that Accuray is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Accuray
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Orthofix Medical
2 Very Positive mention(s)
4 Positive mention(s)
10 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Accuray and Orthofix Medical tied by winning 9 of the 18 factors compared between the two stocks.

Get Accuray News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARAY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARAY vs. The Competition

MetricAccuraySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$197.44M$4.58B$5.81B$8.43B
Dividend YieldN/A36.92%4.76%3.97%
P/E Ratio-38.4030.3924.9419.24
Price / Sales0.4450.34368.46110.22
Price / CashN/A51.0838.0534.58
Price / Book4.276.267.374.28
Net Income-$15.55M$67.64M$3.18B$247.04M
7 Day Performance-4.95%-5.18%-2.94%-3.26%
1 Month Performance-17.60%-9.68%-6.84%-6.57%
1 Year Performance-24.41%10.60%12.61%4.01%

Accuray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARAY
Accuray
3.2052 of 5 stars
$1.92
-4.5%
N/A-26.4%$197.44M$453.14M-38.401,040
OFIX
Orthofix Medical
2.9255 of 5 stars
$18.15
+1.1%
$23.33
+28.6%
+30.6%$693.51M$746.64M-5.801,634Gap Up
SRDX
Surmodics
4.5707 of 5 stars
$35.01
+0.5%
$50.00
+42.8%
-3.5%$500.64M$126.08M-34.66450Short Interest ↓
Analyst Revision
News Coverage
Positive News
ANGO
AngioDynamics
4.3527 of 5 stars
$10.08
-2.4%
$13.00
+29.0%
+69.5%$407.90M$286.50M-1.79760Positive News
RMTI
Rockwell Medical
4.2859 of 5 stars
$1.75
-1.1%
$6.00
+242.9%
+1.9%$56.56M$98.92M-35.00300Short Interest ↓
RSLS
ReShape Lifesciences
0.3291 of 5 stars
$1.36
+21.4%
N/A-89.2%$993,000.00$8.18M0.0050Gap Up
High Trading Volume
ABT
Abbott Laboratories
4.9018 of 5 stars
$134.81
-0.1%
$133.06
-1.3%
+18.1%$233.82B$41.95B17.62114,000Options Volume
Positive News
ISRG
Intuitive Surgical
4.2726 of 5 stars
$591.01
-0.1%
$613.10
+3.7%
+42.5%$210.51B$8.35B92.2015,638Insider Trade
Positive News
BSX
Boston Scientific
4.2403 of 5 stars
$104.30
-0.2%
$107.39
+3.0%
+56.1%$153.92B$16.75B83.4448,000Analyst Forecast
Positive News
SYK
Stryker
4.5559 of 5 stars
$388.11
+1.4%
$422.15
+8.8%
+11.7%$148.09B$22.60B50.0153,000Positive News
MDT
Medtronic
4.6134 of 5 stars
$90.27
+0.4%
$95.00
+5.2%
+12.7%$115.76B$33.20B27.4495,000Positive News

Related Companies and Tools


This page (NASDAQ:ARAY) was last updated on 3/4/2025 by MarketBeat.com Staff
From Our Partners